BCM
APEN

Boone Capital Management’s Apollo Endosurgery, Inc. APEN Stock Holding History

Boone Capital Management’s Portfolio APEN Stock Details APEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-718,419
Closed -$7.16M – 20
2022
Q4 		$7.16M Buy
+718,419
New +$5.36M 3.68% 12

Other funds holding APEN

CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Boone Capital Management's APEN Position: Q1 2023 in Review

Boone Capital Management sold out of Apollo Endosurgery, Inc. (APEN) in Q1 2023, closing a stake of 718,419 shares — an estimated $7.16M sold.

Boone Capital Management first reported a position in APEN in Q4 2022 and held it in 1 quarter. The position peaked at $7.16M in Q4 2022. 89 funds tracked by Wall St. Rank hold APEN as of Q1 2023.

  • Boone Capital Management reported no remaining Apollo Endosurgery, Inc. position as of Q1 2023 after selling out during the quarter.
  • Boone Capital Management sold 718,419 Apollo Endosurgery, Inc. shares in Q1 2023, an estimated $7.16M.
  • Boone Capital Management first reported a position in Apollo Endosurgery, Inc. in Q4 2022 and held it in 1 quarter.
  • Boone Capital Management's Apollo Endosurgery, Inc. position peaked at $7.16M in Q4 2022.
  • 89 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q1 2023.

Based on Boone Capital Management's 13F filing for Q1 2023, filed 15 May 2023.